Effectiveness of the 23-Valent Pneumococcal Polysaccharide Vaccine Against Community-Acquired Pneumonia in the General Population Aged >=60 Years: 3 Years of Follow-up in the CAPAMIS Study

2014 ◽  
Vol 58 (7) ◽  
pp. 909-917 ◽  
Author(s):  
O. Ochoa-Gondar ◽  
A. Vila-Corcoles ◽  
T. Rodriguez-Blanco ◽  
F. Gomez-Bertomeu ◽  
E. Figuerola-Massana ◽  
...  
Keyword(s):  
General Population ◽  
Community Acquired Pneumonia ◽  
Polysaccharide Vaccine ◽  
Pneumococcal Polysaccharide Vaccine

scholarly journals In-Hospital Pneumococcal Polysaccharide Vaccination Is Associated With Detection of Pneumococcal Vaccine Serotypes in Adults Hospitalized for Community-Acquired Pneumonia

2015 ◽  
Vol 2 (4) ◽  
Author(s):  
Carlos G. Grijalva ◽  
Richard G. Wunderink ◽  
Yuwei Zhu ◽  
Derek J. Williams ◽  
Robert Balk ◽  
...  
Keyword(s):  
Pneumococcal Vaccine ◽  
Community Acquired Pneumonia ◽  
Polysaccharide Vaccine ◽  
Urine Collection ◽  
Pneumococcal Polysaccharide Vaccine ◽  
Test Results ◽  
Pneumococcal Serotypes ◽  
False Positive Test ◽  
Pneumococcal Antigen ◽  
Urine Specimens

Abstract During an etiology study of adults hospitalized for pneumonia, in which urine specimens were examined for serotype-specific pneumococcal antigen detection, we observed that some patients received 23-valent pneumococcal polysaccharide vaccine before urine collection. Some urine samples became positive for specific vaccine pneumococcal serotypes shortly after vaccination, suggesting false-positive test results.

Use of Pneumococcal Polysaccharide Vaccine in Preventing Otitis Media in Infants: Different Results Between Racial Groups

PEDIATRICS ◽  
1984 ◽  
Vol 73 (1) ◽  
pp. 79-81
Author(s):  
V. M. Howie ◽  
John Ploussard ◽  
John L. Sloyer ◽  
James C. Hill
Keyword(s):  
Otitis Media ◽  
Polysaccharide Vaccine ◽  
The Other ◽  
Pneumococcal Vaccines ◽  
Racial Groups ◽  
Pneumococcal Polysaccharide Vaccine ◽  
Follow Up Care

A total of 133 children between 6 and 11 months of age with at least one episode of otitis media were given one of two pneumococcal vaccines. One vaccine contained 25 µm of types 1, 3, 6, 7, 14, 18, 19, and 23 and the other vaccine (control) contained 25 µm of types 2, 4, 5, 8, 9, 12, and 25. Follow-up care of the 65 black infants revealed significantly more otitis media visits in those infants receiving the control vaccine. Among the 68 white infants there was no difference between control and vaccine groups after vaccination.

Sign in / Sign up

Export Citation Format

Share Document